Personalized Tuberculosis Care for Drug-Resistant Tuberculosis

Keyphrases

• Multidrug-resistant Tuberculosis (MDR-TB) 100%
• Tuberculosis Care 100%
• Therapeutic Drug Monitoring 60%
• Drug Exposure 60%
• XDR-TB 40%
• Loss-of-susceptibility 40%
• Comorbidity 20%
• Surgical Intervention 20%
• Intra-individual 20%
• Blood Samples 20%
• Disease Severity 20%
• Genetic Background 20%
• Body Composition 20%
• Drug Administration 20%
• Fluoroquinolones 20%
• Rifampicin 20%
• Nutritional Status 20%
• Minimum Inhibitory Concentration 20%
• Appropriate Technology 20%
• Low-resource Settings 20%
• Co-infection 20%
• Gender Composition 20%
• Linezolid 20%
• Therapeutic Vaccination 20%
• Extensively Drug-resistant Tuberculosis 20%
• Bedaquiline 20%
• TB Drugs 20%
• Host-directed Therapy 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Therapeutic Drug Monitoring 100%
• Extensively Drug-Resistant Tuberculosis 100%
• Drug Resistant Tuberculosis 100%
• Multi-Drug-Resistant Tuberculosis 66%
• Comorbidity 33%
• Bedaquiline 33%
• Vaccination Policy 33%
• Quinolone Derivative 33%
• Isoniazid 33%
• Drug Administration 33%
• Rifampicin 33%
• Disease Severity 33%
• Linezolid 33%
• Mixed Infection 33%